IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Jenburkt Pharmaceuticals

BSE:JENBURPH · ISIN INE354A01013

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Jenburkt Pharmaceuticals

Overview

Evidence state

Company record at a glance

Coverage in progress

Latest filing: Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Observed

Latest ownership: promoter group 46.62% and public 53.38% as of 30 Jun 2026.

Exchange XBRL
Material events

What changed recently

Open timeline →
Observed

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE · exchange filing

Source filing
Observed

Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 41St Annual General Meeting Of The Company Schedule To Be Held On Friday, 04Th September, 2026 Through VC/OAVM.

BSE · exchange filing

Source filing
Observed

Jenburkt Pharmaceuticals Ltd - 524731 - Reg. 34 (1) Annual Report.

BSE · annual report

Source filing
Observed

Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.

BSE · financial results

Source filing
Reported financials

Awaiting structured filing

Full financials →
No reconciled records in this module yet

Structured financial facts have not been reconciled.

Ownership

30 Jun 2026

Full shareholding →
Promoter group
46.62%
Public
53.38%
Employee trust
N/A

Observed BSE shareholding XBRL